FDA rejects Mylan's generic version of GSK's Advair
March 29, 2017 at 14:21 PM EDT
The U.S. drugmaker did not disclose the reason behind the rejection, but said it was reviewing the FDA's response.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.